Posted by Michael Wonder on 23 Dec 2020
TricValve transcatheter bicaval valves system granted designation as breakthrough device by the U.S. FDA
22 December 2020 - P+F Products + Features has been granted designation as a breakthrough bevice for the company's lead product, the TricValve transcatheter bicval valves system by the U.S. FDA on 15 December 2020.
The TricValve is a system of two self-expanding biological valves for the treatment of patients with haemodynamically relevant tricuspid insufficiency and caval reflux.
